当前位置：
X-MOL 学术
›
Transfus. Med. Rev.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
HTLV-I/II prevalence in different geographic locations.
Transfusion Medicine Reviews ( IF 4.5 ) Pub Date : 2003-12-23 , DOI: 10.1016/j.tmrv.2003.10.004 Hans Vrielink 1 , Henk W Reesink
Transfusion Medicine Reviews ( IF 4.5 ) Pub Date : 2003-12-23 , DOI: 10.1016/j.tmrv.2003.10.004 Hans Vrielink 1 , Henk W Reesink
Affiliation
Human T-cell lymphotropic virus (HTLV) type I (HTLV-I) is the etiological agent of adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). HTLV-II is a closely related virus, and this infection is not clearly associated with clinical disease, although neurologic disorders are observed resembling HAM/TSP. Prevalence rates for HTLV-I infection in the general population are greater than 1% in the Caribbean Basin, Central Africa, and South Japan. In most other areas in the world, as far as we know, HTLV-I/II infections are mainly found in high-risk groups (ie, immigrants from endemic areas, their offspring, their sexual contacts and in patients and intravenous injection users attending sexually transmitted disease clinics). Also, a high rate of infection for both HTLV-I and HTLV-II infection was observed in the native Amerindian population in North America as well as South America. Blood donors are routinely screened for HTLV-I/II in North America, several countries in Europe, Japan, and Taiwan.
更新日期：2019-11-01
京公网安备 11010802027423号